Technology
The company is offering 7.9 million of its common stock at an initial price of $19 per share, with shares trading under the ticker symbol OMDA.
HIMSS25
Getting every image, anywhere, to anyone who has the right to the image, including physicians and patients through the personal health record, is a key goal, says Dr. David Kaelber, Cleveland MetroHealth's chief medical informatics officer.
It has shown potential to significantly reduce pain intensity.
Through the acquisition, the company will expand its operations in the UK and launch operations in Germany, France and Ireland.
Alexandre Momeni, a partner at General Catalyst, describes how the VC firm funds visionary founders building frontier technologies while balancing high-risk bets with responsible innovation and strategic portfolio construction.
Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.
The company will grow its clinical team and expand its offerings across GI partner clinics representing 700 physicians, after an 800% rise in patient volume.
The partnership will help self-insured employers satisfy their fiduciary obligations and lower prescription drug costs and provide members access to inexpensive medications.
The company aims to create a tech-driven, interoperable healthcare system that improves the patient experience while streamlining communication across brands.
Pupil Labs’ eye-tracking software will connect with Cognixion's Axon-R SDK interface, permitting data collection and analysis across platforms.